Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TISA-818-Inj in Acute Respiratory Distress Syndrome
NCT07319351Phase 2Completed
- Sponsor
- EnliTISA
- Start
- Oct 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TISA-818 in acute respiratory distress syndrome (ARDS), sponsored by EnliTISA. Started Oct 2023; status: completed.
02
Drugs
TISA-818
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07319351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07319351.